Immix Biopharma, Inc. (IMMX)
NASDAQ: IMMX · Real-Time Price · USD
10.97
+0.05 (0.46%)
At close: Aug 14, 2026, 4:00 PM EDT
10.77
-0.20 (-1.80%)
After-hours: Aug 14, 2026, 7:34 PM EDT
Immix Biopharma Employees
As of December 31, 2025, Immix Biopharma had 21 total employees, including 18 full-time and 3 part-time employees. The number of employees did not change compared to the previous year.
Employees
21
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,900,820
Market Cap
784.79M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 21 | 0 | - | 21 | 0 |
| Dec 31, 2024 | 21 | 4 | 23.53% | 18 | 3 |
| Dec 31, 2023 | 17 | 6 | 54.55% | 14 | 3 |
| Dec 31, 2022 | 11 | 9 | 450.00% | 9 | 2 |
| Dec 31, 2021 | 2 | - | - | 2 | 0 |
| Sep 30, 2021 | 2 | - | - | 2 | 0 |
| Jun 30, 2021 | 2 | - | - | 2 | 0 |
Related Stocks
| Company Name | Employees |
|---|---|
| Pharming Group | 407 |
| Phathom Pharmaceuticals | 371 |
| Rigel Pharmaceuticals | 174 |
| DBV Technologies | 170 |
| Aura Biosciences | 113 |
| Silence Therapeutics | 88 |
| Oculis Holding AG | 60 |
| Achieve Life Sciences | 28 |
IMMX News
- 4 days ago - Immix Biopharma price target lowered to $19 from $20 at Morgan Stanley - TheFly
- 4 days ago - Immix Biopharma Slides: Corporate presentation - Filings
- 5 days ago - Immix Biopharma price target raised to $25 from $20 at H.C. Wainwright - TheFly
- 8 days ago - Immix Biopharma Quarterly report: Q2 2026 - Filings
- 9 days ago - IMMX Investors Have Opportunity to Join Immix Biopharma, Inc. Fraud Investigation with SBS Law - Business Wire
- 11 days ago - Immix Biopharma to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference - GlobeNewsWire
- 24 days ago - Immix Biopharma initiated with a Buy at Needham - TheFly
- 25 days ago - Immix Biopharma Investigated by the Portnoy Law Firm - GlobeNewsWire